RT @IlindelatorreMD: Por cada paciente que finalmente dio positivo tanto para el SARS-CoV-2 como para una infección bacteriana concurrente…
RT @IlindelatorreMD: Por cada paciente que finalmente dio positivo tanto para el SARS-CoV-2 como para una infección bacteriana concurrente…
Por cada paciente que finalmente dio positivo tanto para el SARS-CoV-2 como para una infección bacteriana concurrente que estaba presente a su llegada, otros 20 recibieron antibióticos aunque resultaron ser innecesarios. https://t.co/Ea196GosVJ
"The prevalence of confirmed community-onset bacterial co-infections was low. Despite this, half of patients received early empiric antibacterial therapy...Reducing #COVID-19 test turnaround time...could improve antibacterial use." -IDSA. Read more: https:
Use of early empiric antibiotics high in COVID-19 https://t.co/4fFr3HcJq2 Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/FHbWwTTsfq
Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study | Clinical Infectious Diseases | Oxford Academic https://t.co/vNy2igsOh3
RT @sanfordguide: In the age of COVID, antimicrobial stewardship is often overlooked. AMS programs are more important now than ever! #COV…
In the age of COVID, antimicrobial stewardship is often overlooked. AMS programs are more important now than ever! #COVID19 #antimicrobialstewardship https://t.co/csJqC9U9bh
Important publication that speaks to the importance of mindful antibiotic prescribing in persons with #COVID19. #BeASteward https://t.co/rbGRmmCu1M
RT @luizacaires3: Link para o artigo científico: https://t.co/c6PJcfr1zK
Link para o artigo científico: https://t.co/c6PJcfr1zK
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
2020/3/13-6/18にミシガン州の38の病院でCOVID-19入院患者約1700人の半数以上が早期に抗菌薬治療を受ける 一部では抗菌薬使用率84%も細菌感染合併は僅か Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19 https://t.co/HykI4nL2OU https://t.co/QarEBbzxnW
RT @DoctorYasmin: This study of Covid patients hospitalized in Michigan found more than half received antibiotics. But of those given antib…
RT @DoctorYasmin: This study of Covid patients hospitalized in Michigan found more than half received antibiotics. But of those given antib…
This study of Covid patients hospitalized in Michigan found more than half received antibiotics. But of those given antibiotics, 96.5% were infected with the new coronavirus only (no additional bacterial infection) making the antibiotics unnecessary. https
RT @OurghanlianC: Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies in…
RT @OurghanlianC: Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies in…
RT @OurghanlianC: Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies in…
Mode info:
RT @OurghanlianC: Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies in…
RT @OurghanlianC: Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies in…
RT @OurghanlianC: Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies in…
Nouveau rappel que dans l'infection à SARS-CoV-2, les surinfections initiales sont rares (<5%) et les antibiothérapies inutiles trop fréquentes (>50%) #COVID19 https://t.co/7ofgZDMTsD
How has #COVID19 impacted #antibiotics use? PSEP members @ValerieVaughnMD @Payal_Patel @lindsay_petty @vineet_chopra and @flandersumich teamed up on this one! Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection... https://t.co/2JFVY
RT @KavithaSaravu: Community onset Bacterial confections with #COVID__19 are rare at 3.5%. Avoid empiric antibiotics. #stewardship
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
Síganle...
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @UM_IntMedCMRs: Great work by @UMIntMed faculty @ValerieVaughnMD and colleagues @Tejal_N_Gandhi @lindsay_petty @Payal_Patel @HalliePres…
Great work by @UMIntMed faculty @ValerieVaughnMD and colleagues @Tejal_N_Gandhi @lindsay_petty @Payal_Patel @HalliePrescott and others exploring empiric antibiotic use in #COVID19! Come learn from them! #WhyUMichIM
Community onset Bacterial confections with #COVID__19 are rare at 3.5%. Avoid empiric antibiotics. #stewardship
“The prevalence of confirmed community-onset bacterial co-infections was low. Despite this, half of patients received early empiric antibacterial therapy; use varied widely by hospital. Reducing COVID-19 test turnaround time could improve antibacterial use
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @UM_IHPI: NEW work from the #COVID19 data collaborative launched by our members early in the #pandemic: https://t.co/j4Y1RGEI6k
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @VisweshPharmD: Can we stop putting every COVID-19 patient on empirical antibiotics? Save it for only the sickest or based on PCT perhap…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @chngin_the_wrld: Today's #shoutout to #womenInSTEM goes to @ValerieVaughnMD for her #CID paper on high levels of empiric #antibiotic tr…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @nbennett04: 💪 work by this group further solidifying the data. Fortunate our physicians continue to trend towards lower abx prescribing…
Las co-infecciones bacteria-virus en pacientes con SARS-CoV-2 es baja. Una oportunidad para el uso responsable de antibióticos #stewardship https://t.co/NUPAJhi6Zq
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
Word!!!
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
Important work 🙌🏾. The variation in empiric antimicrobial use 27 - 84% across 38 MI hospitals around #COVID is staggering - likely reflective of practice across country and fortunately improved with time #IDtwitter
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
RT @ValerieVaughnMD: Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infe…
Check out our new study in #CID on antibiotic use in #COVID19. Lots of empiric abx, few community-onset bacterial infections. Good news? Abx use⬇️over time. How to help? To start, quicker COVID test turnaround times. @umichmedicine https://t.co/WIlXGg08KR
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @sanchak74: How will you test for the presence of a hard-to-culture bacterial pathogen which is not included in the test panel? If some…
RT @chngin_the_wrld: Today's #shoutout to #womenInSTEM goes to @ValerieVaughnMD for her #CID paper on high levels of empiric #antibiotic tr…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @chngin_the_wrld: Today's #shoutout to #womenInSTEM goes to @ValerieVaughnMD for her #CID paper on high levels of empiric #antibiotic tr…
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @chngin_the_wrld: Today's #shoutout to #womenInSTEM goes to @ValerieVaughnMD for her #CID paper on high levels of empiric #antibiotic tr…
RT @chngin_the_wrld: Today's #shoutout to #womenInSTEM goes to @ValerieVaughnMD for her #CID paper on high levels of empiric #antibiotic tr…
Today's #shoutout to #womenInSTEM goes to @ValerieVaughnMD for her #CID paper on high levels of empiric #antibiotic treatment despite low levels of community-onset bacterial co-infection in patients hospitalized with #COVID19. #AMR #superbugs https://t.co/
RT @ABsteward: NEW 🔥🔥Multi-Hospital Cohort Study #CID @ValerieVaughnMD and lineup of #IDTwitter 🌟s Empiric Antibacterial Therapy and Commun…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
Can we stop putting every COVID-19 patient on empirical antibiotics? Save it for only the sickest or based on PCT perhaps, but not everyone. If started, should be rapidly discontinued by day 3 in most cases. https://t.co/lPZqWpaSOG
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: 📍Of pts prescribed empiric Abx 54.4% had their Abx stopped 1 day after #COVID19 tests returned positive 📍Of pts that had Abx…
RT @ABsteward: 📍~57% of hospitalized patients with #COVID19 were prescribed early empiric antibacterial therapy 📍only 3.5% of COVID-19 pati…
RT @sanchak74: How will you test for the presence of a hard-to-culture bacterial pathogen which is not included in the test panel? If some…
RT @sanchak74: How will you test for the presence of a hard-to-culture bacterial pathogen which is not included in the test panel? If some…
How will you test for the presence of a hard-to-culture bacterial pathogen which is not included in the test panel? If someone said: "this is not Cov2" without doing the proper RT-PCR, would you accept it? The 3.5% means nothing. https://t.co/lsttnei6qZ